Correspondence 0001493152-23-032099 from Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)
Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)
Date: Sept. 8, 2023 · CIK: 0000793171 · Accession: 0001493152-23-032099
AI Filing Summary & Sentiment
File numbers found in text: 333-267366
Letter
Cherry Creek Drive South, Suite 720
Denver, Colorado 80209
September 8, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky, Suzanne Hayes, Julie Sherman and Kevin Vaughn
Re: Vitro Biopharma, Inc.
Registration Statement on Form S-1
Filed on August 29, 2023
File No. 333-267366
Ladies and Gentleman:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned registrant hereby respectfully requests that the effective date of the Registration Statement on Form S-1 referred to above (the “Registration Statement”) be accelerated so that the same will become effective at 5:00 p.m. Eastern Time on September 12, 2023, or as soon thereafter as practicable. In making this acceleration request, the undersigned registrant acknowledges that it is aware of its obligations under the Act.
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Polsinelli PC, by calling Scott Berdan at (303) 583-8235.
Thank you for your assistance with this matter.
Sincerely,
VITRO BIOPHARMA, INC.
Show Raw Text
CORRESP
1
filename1.htm
3200
Cherry Creek Drive South, Suite 720
Denver,
Colorado 80209
September
8, 2023
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Attn:
Joshua Gorsky, Suzanne Hayes, Julie Sherman and Kevin Vaughn
Re:
Vitro
Biopharma, Inc.
Registration
Statement on Form S-1
Filed
on August 29, 2023
File
No. 333-267366
Ladies
and Gentleman:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned registrant hereby respectfully
requests that the effective date of the Registration Statement on Form S-1 referred to above (the “Registration Statement”)
be accelerated so that the same will become effective at 5:00 p.m. Eastern Time on September 12, 2023, or as soon thereafter as practicable.
In making this acceleration request, the undersigned registrant acknowledges that it is aware of its obligations under the Act.
Once
the Registration Statement has been declared effective, please orally confirm that event with our counsel, Polsinelli PC, by calling
Scott Berdan at (303) 583-8235.
Thank
you for your assistance with this matter.
Sincerely,
VITRO BIOPHARMA, INC.
/s/ Nathan Haas
Name:
Nathan
Haas
Title:
Chief
Financial Officer
cc:
Scott
Berdan, Esq., Polsinelli PC
Tyler
Weigel, Esq., Polsinelli PC
Shashi
Khiani, Esq., Polsinelli PC